Publicacións (85) Publicacións de Ana Belen Cid Alvarez

2024

  1. A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767

  2. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

2023

  1. Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry

    Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64

  2. Diferencias regionales en la atención al IAMCEST en España. Datos del Registro de Código Infarto ACI-SEC

    REC: Interventional Cardiology, Vol. 5, Núm. 2, pp. 118-128

  3. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

    Thrombosis Research, Vol. 224, pp. 46-51

  4. Documento de posicionamiento de la ACI-SEC sobre la modificación de la placa en el tratamiento de las lesiones calcificadas

    REC: Interventional Cardiology, Vol. 5, Núm. 1, pp. 46-61

  5. Remnant cholesterol in patients admitted for acute coronary syndromes

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 340-348

  6. Results from the ACI-SEC Infarction Code Registry. The ECG also exists. Response

    Revista Espanola de Cardiologia

  7. Selection of the best of 2022 in percutaneous coronary interventions

    REC: CardioClinics, Vol. 58, pp. S15-S20

  8. Women, cardiology, and interventional subspecialties

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 70-71

2022

  1. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

  2. Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 669-680

  3. Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies

    European Journal of Internal Medicine, Vol. 105, pp. 69-76

  4. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  5. Instantaneous Wave-Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations with Fractional Flow Reserve/Intravascular Ultrasound and Prognostic Implications: The iLITRO-EPIC07 Study

    Circulation: Cardiovascular Interventions, Vol. 15, Núm. 11, pp. 861-871

  6. Prognostic impact of renal function trajectories in patients with STEMI and kidney dysfunction undergoing primary percutaneous coronary intervention: An analysis of ten years all-comers registry

    Hellenic Journal of Cardiology, Vol. 66, pp. 1-10

  7. Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort

    International Journal of Cardiology, Vol. 367, pp. 90-98

  8. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

    Acta Diabetologica, Vol. 59, Núm. 2, pp. 163-170

2021

  1. Actualización de las recomendaciones sobre requisitos y equipamiento en cardiología intervencionista.: Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares de la Sociedad Española de Cardiología y la Asociación Española de Enfermería en Cardiología

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 33-44

  2. Aplicación prospectiva de un protocolo antitrombótico ajustado a riesgo isquémico/hemorrágico en pacientes mayores de 75 años tratados con stents liberadores de everolimus: Registro SIERRA-75 (EPIC-05)

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 15-15